American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

Meningitis Outbreak Associated with Potentially Contaminated Steroid

By News Staff

The CDC is coordinating a multistate fungal meningitis investigation among patients who recently received epidural steroid injections.
According to the CDC, 47 people have presented with the illness in seven states, with Tennessee reporting the highest number of cases at 29. Five people have died. In several of the people affected, the meningitis was caused by a common fungus that rarely causes the disease. The source of the fungus has not yet been identified, and the cause of infections in the other patients still is being assessed.

According to a joint Oct. 4 CDC/FDA health advisory (2-page PDF; About PDFs), interim data indicate the cases are associated with a potentially contaminated steroid -- methylprednisolone acetate -- manufactured by New England Compounding Center in Framingham, Mass. The company recalled three lots on Sept. 25.

The recalled methylprednisolone acetate (PF) 80 mg/ml injection lots are
  • #05212012@68, BUD 11/17/2012;
  • #06292012@26, BUD 12/26/2012; and
  • #08102012@51, BUD 2/6/2013.
The FDA and CDC are recommending that physicians contact patients who have had an injection using any of the three lots of the steroid. For patients who received epidural injection and have symptoms of meningitis or basilar stroke, a diagnostic lumbar puncture (LP) should be performed, if not contraindicated. Because presenting symptoms of some patients with meningitis have been mild and not classic for meningitis, physicians should have a low threshold for LP.

Physicians and patients are encouraged to report adverse events associated with the steroid to the FDA's MedWatch program.

Share this on AAFP Connection

Search AAFP News Now

 

Health of the Public

Though Waning, H7N9 Still Poses Pandemic Potential

AUA Says No to Routine PSA Screening

AAFP Criticizes Appeal of Plan B One-Step Ruling

AAFP to Hospitals: Stop Early Elective Deliveries

AAFP, USPSTF Differ Somewhat on HIV Screening Guidance

Zoledronic Acid Confers Both Pros, Cons

ACP Issues Guidance on PSA Screening

Abbott Recalls FreeStyle InsuLinx Blood Glucose Meter

Discuss Drug Options With Women at Risk for Breast Cancer

Shingles Vaccine Effective, But Uptake Is Low

Evidence Lacking to Make Oral Cancer Screening Recommendation

Two External Guidelines Get Qualified AAFP Endorsement

USPSTF Recommends BRCA Testing for High-risk Women

Primary Care, Public Health Look for Ways to Integrate

Malfunction Prompts Glucose Meter Recall

Evidence Lacking on PAD Screening, Says USPSTF

Azithromycin Poses Arrhythmia Risk, Says FDA

Vets With PTSD Often Prescribed Inappropriate Meds

AIM-HI Offers Grants to Combat Childhood Obesity

USPSTF Says No to Low-dose Vitamin D, Calcium to Prevent Fractures

PCV13, HibMenCY Vaccine Changes Approved by ACIP

AAFP, Other Groups Release More Choosing Wisely Lists

National Office Champions Tobacco Cessation Project Successful

USPSTF Issues Draft Statement on Glaucoma Screening

Study Examines Overuse, Inappropriate Use of Health Services

Apply to Become an AAFP Vaccine Science Fellow

Study Looks to Reduce PSA Screening Risks

AAP Issues New Clinical Guidance on Type 2 Diabetes

CDC: Adult Vaccination Rates Still Too Low

Pertussis Outbreaks Declining, but Immunization Still Key

2013 Immunization Schedules Include Several Changes

FDA Warns of Liver Injury Risk With Samsca Use

FDA Approves First Recombinant Trivalent Influenza Vaccine

AAFP, USPSTF: Screen Women of Childbearing Age for Partner Violence

Breast Cancer Screening in Older Women Costly, Likely Ineffective

CDC Gives Flu Update, Urges Continued Vaccination

Aerobic Exercise Beats Resistance Training for Weight Control